A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Care Access - Tampa
Clinical research site in Tampa, Florida · 5106 N ARMENIA AVE STE 4, TAMPA, FL 33603-1433 · (813) 931-2366
Part of Care Access
As of July 2026, 3 paid clinical trials are recruiting at Care Access - Tampa in Tampa, Florida. Active studies at this site cover conditions such as Alzheimer Disease, Dementia and Plaque, Amyloid. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Care Access - Tampa (3)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
127 locations incl. Gilbert
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
for Obesity
25 locations incl. Chandler
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07035093·Phase 3·Recruiting·Listed Jun 2025
More research sites in Tampa
- Moffitt Cancer Center (267 trials)
- University of South Florida (118 trials)
- Tampa General Hospital (66 trials)
- Saint Joseph's Hospital/Children's Hospital-Tampa (37 trials)
- Moffitt Cancer Center - McKinley Campus (26 trials)
- Moffitt Cancer Center-International Plaza (22 trials)
- Moffit Cancer Center (13 trials)
- K2 Medical Research - Tampa (8 trials)
- St. Joseph's Children's Hospital (8 trials)
- USF Health (8 trials)